ClinVar Miner

Submissions for variant NM_004656.4(BAP1):c.1946G>A (p.Cys649Tyr)

gnomAD frequency: 0.00011  dbSNP: rs151308667
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000232984 SCV000288747 uncertain significance BAP1-related tumor predisposition syndrome 2024-01-19 criteria provided, single submitter clinical testing This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 649 of the BAP1 protein (p.Cys649Tyr). This variant is present in population databases (rs151308667, gnomAD 0.02%). This missense change has been observed in individual(s) with renal cell carcinoma (PMID: 24166983). ClinVar contains an entry for this variant (Variation ID: 240053). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BAP1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect BAP1 function (PMID: 33240524). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000568347 SCV000664603 likely benign Hereditary cancer-predisposing syndrome 2023-02-06 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Color Diagnostics, LLC DBA Color Health RCV000568347 SCV000902750 likely benign Hereditary cancer-predisposing syndrome 2016-11-14 criteria provided, single submitter clinical testing
GeneDx RCV001589192 SCV001824688 uncertain significance not provided 2023-10-04 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Published functional studies suggest no damaging effect: demonstrated nuclear localization and de-ubiquitination activity comparable to wild type (Hong et al., 2020); Observed in individuals with clear cell renal cell carcinoma or unspecified BAP1-related disease (Gossage et al., 2014; Zauderer et al., 2019); This variant is associated with the following publications: (PMID: 28873162, 33240524, 31323388, 24166983)
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV001589192 SCV002009772 uncertain significance not provided 2021-11-03 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000568347 SCV002537274 likely benign Hereditary cancer-predisposing syndrome 2020-10-13 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV002267995 SCV002550643 uncertain significance not specified 2024-02-06 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.